Company Profile - Shiseido Co Ltd

Introduction

Shiseido Co Ltd (Shiseido) develops, produces and distributes cosmetics, health and beauty care products. The company’s product portfolio includes skincare products, shampoo and hair care products, body care products, fragrances, styling products, hair color products, perm products and cosmetics. The company markets its products under Shiseido, Cle de Peau Beaute, Nars, Issey Miyake, narciso rodriguez, Elixir, Anessa, Senka, Baum and Shiseido Professional brand names. Shiseido sells these products through department and cosmetic stores, perfumeries, drug stores and mass merchandising stores. The company operates subsidiaries, factories and production sites in Japan, the Americas, the Middle East and Africa, Europe and Asia-Pacific. Shiseido is headquartered in Chuo-Ku, Tokyo, Japan.

Company info

Country (HQ): Japan
Sector: Consumer Packaged Goods
Market Cap (US$ m): 20,115
Revenue (US$ m): 7,885 (2022)

Innovation ranking

451

Innovation score

Closest peers in the Consumer Packaged Goods sector

Innovation Ranking

Company
Headquarters
Sector

LG Electronics Inc

South Korea

Consumer Packaged Goods

Midea Group Co Ltd

China

Consumer Packaged Goods

Shiseido Co Ltd

Japan

Consumer Packaged Goods

Pandora AS

Denmark

Consumer Packaged Goods

Morinaga & Co Ltd

Japan

Consumer Packaged Goods

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers